← Back to investors
Marshall Wace
angelActive growth-stage investor. 2 investments tracked, primarily in infrastructure and biotech. Recent: Ray Therapeutics: $125 Million Series B, ConsenSys.
Rounds (3)
| Date | Project | Type | Amount | Valuation | Sector |
|---|---|---|---|---|---|
| Jul 14, 2026 | Draig Therapeutics | series_b | $65.0M | — | biotech |
| Apr 21, 2026 | Ray Therapeutics: $125 Million Series B | series_b | $125.0M | — | biotech |
| Nov 16, 2021 | ConsenSys | series_c | $200.0M | — | infrastructure |
Want to know if Marshall Wace is the right fit for your raise? Get matched with the right investors.
Get matched with investors